No Cover Image

Journal article 480 views 126 downloads

Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial / Steve, Bain

Diabetes Care, Volume: 39, Issue: 2, Pages: 222 - 230

Swansea University Author: Steve, Bain

Check full text

DOI (Published version): 10.2337/dc14-2883

Published in: Diabetes Care
ISSN: 0149-5992 1935-5548
Published: 2016
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa25946
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2016-01-22T02:00:01Z
last_indexed 2019-09-02T19:53:08Z
id cronfa25946
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2019-09-02T16:42:35.3385498</datestamp><bib-version>v2</bib-version><id>25946</id><entry>2016-01-21</entry><title>Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-01-21</date><deptcode>PMSC</deptcode><abstract/><type>Journal Article</type><journal>Diabetes Care</journal><volume>39</volume><journalNumber>2</journalNumber><paginationStart>222</paginationStart><paginationEnd>230</paginationEnd><publisher/><issnPrint>0149-5992</issnPrint><issnElectronic>1935-5548</issnElectronic><keywords/><publishedDay>1</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2016</publishedYear><publishedDate>2016-02-01</publishedDate><doi>10.2337/dc14-2883</doi><url/><notes>&amp;quot;This is an author-created, uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association (ADA), publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available online at http://care.diabetesjournals.org/content/39/2/222.</notes><college>COLLEGE NANME</college><department>Medicine</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PMSC</DepartmentCode><institution>Swansea University</institution><lastEdited>2019-09-02T16:42:35.3385498</lastEdited><Created>2016-01-21T14:19:50.6885332</Created><path><level id="1">Swansea University Medical School</level><level id="2">Medicine</level></path><authors><author><firstname>Melanie J.</firstname><surname>Davies</surname><order>1</order></author><author><firstname>Stephen C.</firstname><surname>Bain</surname><order>2</order></author><author><firstname>Stephen L.</firstname><surname>Atkin</surname><order>3</order></author><author><firstname>Peter</firstname><surname>Rossing</surname><order>4</order></author><author><firstname>David</firstname><surname>Scott</surname><order>5</order></author><author><firstname>Minara S.</firstname><surname>Shamkhalova</surname><order>6</order></author><author><firstname>Heidrun</firstname><surname>Bosch-Traberg</surname><order>7</order></author><author><firstname>Annika</firstname><surname>Syr&#xE9;n</surname><order>8</order></author><author><firstname>Guillermo E.</firstname><surname>Umpierrez</surname><order>9</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>10</order></author></authors><documents><document><filename>0025946-25012016142401.pdf</filename><originalFilename>Davies2015.pdf</originalFilename><uploaded>2016-01-25T14:24:01.2430000</uploaded><type>Output</type><contentLength>1193138</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><action/><embargoDate>2017-01-30T00:00:00.0000000</embargoDate><documentNotes/><copyrightCorrect>true</copyrightCorrect></document></documents></rfc1807>
spelling 2019-09-02T16:42:35.3385498 v2 25946 2016-01-21 Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2016-01-21 PMSC Journal Article Diabetes Care 39 2 222 230 0149-5992 1935-5548 1 2 2016 2016-02-01 10.2337/dc14-2883 &quot;This is an author-created, uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association (ADA), publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available online at http://care.diabetesjournals.org/content/39/2/222. COLLEGE NANME Medicine COLLEGE CODE PMSC Swansea University 2019-09-02T16:42:35.3385498 2016-01-21T14:19:50.6885332 Swansea University Medical School Medicine Melanie J. Davies 1 Stephen C. Bain 2 Stephen L. Atkin 3 Peter Rossing 4 David Scott 5 Minara S. Shamkhalova 6 Heidrun Bosch-Traberg 7 Annika Syrén 8 Guillermo E. Umpierrez 9 Steve Bain 0000-0001-8519-4964 10 0025946-25012016142401.pdf Davies2015.pdf 2016-01-25T14:24:01.2430000 Output 1193138 application/pdf Accepted Manuscript true 2017-01-30T00:00:00.0000000 true
title Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
spellingShingle Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
Steve, Bain
title_short Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
title_full Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
title_fullStr Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
title_full_unstemmed Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
title_sort Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve, Bain
author Steve, Bain
format Journal article
container_title Diabetes Care
container_volume 39
container_issue 2
container_start_page 222
publishDate 2016
institution Swansea University
issn 0149-5992
1935-5548
doi_str_mv 10.2337/dc14-2883
college_str Swansea University Medical School
hierarchytype
hierarchy_top_id swanseauniversitymedicalschool
hierarchy_top_title Swansea University Medical School
hierarchy_parent_id swanseauniversitymedicalschool
hierarchy_parent_title Swansea University Medical School
department_str Medicine{{{_:::_}}}Swansea University Medical School{{{_:::_}}}Medicine
document_store_str 1
active_str 0
published_date 2016-02-01T18:55:29Z
_version_ 1658720699621048320
score 10.882135